Effect of rifaximin and paromomycin in the treatment of portal-systemic encephalopathy

Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.

Harold O. Conn, Carroll M. Leevy, Z.R. Vlahcevic et al. · PubMed · 1977 · 649 citations

Medicine, Internal Medicine, Pharmacotherapy +5

Comparison of Lactulose and Neomycin in the Treatment of Chronic Portal-Systemic Encephalopathy

Harold O. Conn, Carroll M. Leevy, Z.R. Vlahcevic et al. · Gastroenterology · 1977 · 628 citations

Medicine, Internal Medicine, Pharmacotherapy +5

Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial.

G Pedretti, Carlo Calzetti, Gabriele Missale et al. · PubMed · 1991 · 88 citations

Pharmacy, Pharmacology, Pharmacotherapy +7

A non-absorbable rifamycin for treatment of hepatic encephalopathy.

Roberto Testa, C. Eftimiadi, G. S. Sukkar et al. · PubMed · 1985 · 58 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Perspectives in hepatic encephalopathy.

Hoyumpa Am, S. Schenker · PubMed · 1982 · 46 citations

Medicine, Neurology, Pathology +11